iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
EHA 2018: Initial results of the INSIGHT trial in multiple myeloma
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma
EHA 2018: Results of the OPTIMISMM trial
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma
Disease control in advanced Hodgkin lymphoma
Rituximab in combination therapies for FL: Interim results
Mapping 3D genome dynamics in B cells
Results from the phase I ICONIC trial
What does progression-free survival mean for breast cancer patients?
Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer
First-in-human phase 1 study of TAK-931 for solid tumours